Skin cancer is the most common neoplasm in the United States with a lifetime risk nearly equal to that of all other cancers combined. Like other cancers, skin carcinogenesis proceeds via the accumulative acquisition of discrete complimentary genetic events. The purpose of this proposal is to dissect the molecular mechanisms that mediate the roles of oncogenes and tumor suppressors in skin carcinogenesis. Based on previous studies the following is proposed: 1) The epidermis has a strong backup system that compensates for p53 loss, which may include novel p53 family members, such as p73. 2) A murine p53-172H mutant (p53m), which is equivalent to the human p53-175H """"""""hot spot mutation"""""""" , may have a gain-of-function that can bypass the compensatory response observed for p53 loss in the epidermis. 3) Activation of the c-ras(Ha) oncogene not only provides the initiation event for skin carcinogenesis, but also contributes greatly to malignant conversion that may be linked to increased genomic instability. 4) Overexpression of the myc oncogene may play a role in skin carcinogenesis and further inhibition of apoptosis by bcl-2 may augment the oncogenic effect of myc. Previously developed transgenic and knockout mouse models, as well as new models will be used to test these hypotheses. The new transgenic models will utilize an inducible, epidermal-specific transgenic/knockout approach which more closely mimics the sporadic focal accumulation of somatic mutations in human tumors. Well-established chemical carcinogenesis protocols and ultraviolet irradiation, which is a critical etiological factor for human skin cancer, will be used as experimental approaches with these mouse models. The development of transgenic models with defined genetic alterations, which have been implicated in human skin cancer, may have a major impact in the development of novel therapeutic approaches in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA052607-11S1
Application #
6500635
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Okano, Paul
Project Start
1990-08-01
Project End
2003-12-31
Budget Start
2001-09-30
Budget End
2001-12-31
Support Year
11
Fiscal Year
2001
Total Cost
$18,750
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Yang, N; Leung, E L-H; Liu, C et al. (2017) INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma. Oncogene 36:4997-5005
Lee, Sangjun; Rodriguez-Villanueva, Julio; McDonnell, Timothy (2017) Restrained Terminal Differentiation and Sustained Stemness in Neonatal Skin by Ha-Ras and Bcl-2. Am J Dermatopathol 39:199-203
Liu, Ying; Snedecor, Elizabeth R; Zhang, Xu et al. (2016) Correction of Hair Shaft Defects through Allele-Specific Silencing of Mutant Krt75. J Invest Dermatol 136:45-51
Riemondy, Kent; Wang, Xiao-jing; Torchia, Enrique C et al. (2015) MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells. Elife 4:
Torchia, Enrique C; Zhang, Lei; Huebner, Aaron J et al. (2013) Aurora kinase-A deficiency during skin development impairs cell division and stratification. J Invest Dermatol 133:78-86
White, Ruth A; Neiman, Jill M; Reddi, Anand et al. (2013) Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest 123:4390-404
Torchia, E C; Caulin, C; Acin, S et al. (2012) Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene 31:2680-90
Chen, Jiang; Roop, Dennis R (2012) Mimicking hair disorders by genetic manipulation of organ-cultured human hair follicles. J Invest Dermatol 132:2312-2314
Terzian, Tamara; Dumble, Melissa; Arbab, Farinaz et al. (2011) Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models. J Pathol 224:540-52
Honeycutt, Kimberly A; Waikel, Rebekah L; Koster, Maranke I et al. (2010) The effect of c-myc on stem cell fate influences skin tumor phenotype. Mol Carcinog 49:315-9

Showing the most recent 10 out of 58 publications